Skip to main content

Table 1 Propensity-matched patient and disease characteristics

From: Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis

 

SM (n = 89)

Control (n = 89)

P Value

Age (years)

65.9 (59.2 – 70.1)

66.4 (59.2 – 71.9)

0.58

Female (%)

28.1

25.8

0.74

Body mass index (kg/m2)

27.1 (24.9 – 30.7)

27.1 (24.7 – 30.2)

0.81

Ejection fraction <30%

5.6

4.5

0.73

Triple-vessel disease (%)

75.3

74.2

0.86

Left main stem disease (%)

23.6

24.7

0.86

Angina class IV (%)

19.1

14.6

0.42

Diabetes (%)

23.6

29.2

0.39

Respiratory disease (%)

37.1

33.7

0.64

Renal dysfunction (%)

6.7

5.6

0.76

Peripheral vascular disease (%)

9.0

7.9

0.79

Current smoker (%)

20.2

20.2

>0.99

Previous myocardial infarction (%)

46.1

51.7

0.45

Hypercholesterolaemia (%)

95.5

95.5

>0.99

Hypertension (%)

57.3

55.1

0.76

Emergent procedure (%)

1.1

1.1

>0.99

Preoperative β-blockers (%)

66.3

64.0

0.75

Preoperative diuretics (%)

33.7

36.0

075

Preoperative heart rate (bpm)

69.1 (61.8 – 81.9)

70.3 (60.6 – 83.2)

0.57

Additive EuroSCORE

4 (2 – 5)

3 (2 – 5)

0.63

Number of grafts (n/patient)

3 (2 – 4)

3 (3 – 4)

0.61

Right-CAD (%)

76.4

71.9

0.49

LIMA (%)

95.5

96.6

0.69

CPB not used (%)

77.5

69.7

0.23

  1. SM, Sotalol and Magnesium; CPB, Cardiopulmonary Bypass; EuroSCORE, European System for Cardiac Operative Risk Evaluation; CAD, Coronary Artery Disease; LIMA, Left Internal Mammary Artery. Categorical variables are shown as a percentage. Continuous variables are shown as a median with 25th and 75th percentiles.